Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Svetlana K Miroshnichenko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Oligonucleotides, Antisense. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian state-funded project for ICBFM SB RAS.
Abstract (Originalsprache)
Colorectal cancer (CRC) remains one of the most aggressive and therapeutically resistant malignancies worldwide. This study examined the molecular mechanisms underlying the anti-oncogenic activity of methanesulfonyl phosphoramidate-modified antisense oligonucleotides (µ-ASOs) targeting miR-21, miR-17, and miR-155, which represent critical oncogenic drivers in CRC. Using human colorectal adenocarcinoma Caco-2 cells transfected with either individual µ-ASOs or their triple combination, we assessed target miRNA downregulation, antiproliferative and anti-migratory activities, and performed extensive proteomic profiling. Protein–protein interaction network analysis of differentially expressed proteins (DEPs) revealed that, beyond modulation of core metabolic processes, each µ-ASO exhibited distinct effects: µ-21 predominantly affected apoptosis, cell cycle, and DNA repair; µ-17 influenced proliferation and chaperone responses; and µ-155 modulated intracellular transport and immune regulation. Combination treatment elicited a unique proteomic signature partially overlapping with monotherapies. The proteomic analysis revealed several validated and putative miRNA-targeted DEPs, including both established and novel candidates in the CRC context: RPL31, CCT2, and CDC37 (miR-21); DNM2, SNRPN, NUP98, and NUP85 (miR-17); as well as RPL17 (miR-155). Expression of these targets correlated with favorable clinical outcomes in CRC patients. This work provides the first comprehensive mechanistic insight into antisense oligonucleotide-mediated miRNA suppression in Caco-2 colorectal adenocarcinoma cells and expands the miRNA target landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
ORCID-Profile: Svetlana K Miroshnichenko, Olga A Patutina, Andrey V Markov, Maxim S Kupryushkin, Marina A Zenkova
Förderung
- Russian Science Foundation
- Russian state-funded project for ICBFM SB RAS
Zitieren
APA
Miroshnichenko, S. K., Patutina, O. A., Markov, A. V., Kupryushkin, M. S., Vlassov, V. V., & Zenkova, M. A. (2025). Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311747
Vancouver
Miroshnichenko SK, Patutina OA, Markov AV, Kupryushkin MS, Vlassov VV, Zenkova MA. Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311747
BibTeX
@article{Miroshnichenko2025,
author = {Miroshnichenko, Svetlana K and Patutina, Olga A and Markov, Andrey V and Kupryushkin, Maxim S and Vlassov, Valentin V and Zenkova, Marina A},
title = {Biological Performance and Molecular Mechanisms of Mesyl MicroRNA-Targeted Oligonucleotides in Colorectal Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311747}
}
EUVIMED